대 한 핵 의 학 회 The Korean Society of Nuclear Medicine
서울특별시 종로구 창신1동 327-2 금호팔레스빌딩 1705호 110-541 전화(02)745-2040 팩스(02)745-3833 E-mail: ksnm11@kornet.net		Gumhopalace B/D #1705 Changshin-Dong, Chongno-Gu, 110-541, Republic of Korea Tel: 82-2-745-2040 Fax: 82-2-745-3833

대 핵 의 : 제2005-009호

시행일자 : 2005.  1.  31.

수    신 : 회원제위

제    목 : 2월 월례집담회 안내문

직인생략

1. 이번 2월 집담회는 증례발표 없이 특강만 있을 예정이오니, 전공의와 전문의 및 핵과학자 선생님들의 많은 참여 있으시기를 바랍니다.

2. 전공의, 전임의의 월례집담회 참석을 독려하여 주시기 바랍니다. 출석 여부를 기록하여, 전공의 수련 점수에 반영할 예정입니다.

- 다    음 -

가. 일  시 : 2005년 2월 16일(수) 오후 6시 30분

나. 장  소 : 삼성서울병원 지하1층 중강당

다. 연 자 :  Bruce R. Line, M.D. (Univ. of Maryland)

라. 제 목 :  Promise and Challenge of PET/CT

대 한 핵 의 학 회	회 장 전 석 길 이사장 김 병 태

[Abstract]

Promise and Challenge of PET/CT

Bruce R. Line, M.D.

Professor of Radiology and Director of Nuclear Medicine,

University of Maryland Medical Center Hospital and

University of Maryland School of Medicine.

This presentation will focus on the promises and challenges of PET/CT encountered in clinical practice and in near future applications.  The great promise of hybrid imaging will be illustrated in clinical oncology and cardiology applicationswith multi-detector CT and co-registered FDG imaging.  Clinical applications in cancers of the head and neck, lung, esophagus and lymphoma will be used to highlight the advantages of diagnostic multi-detector CT/PET fusion. The developing standards of practice for oncology staging, therapy evaluation and detection of recurrent disease will be explored in the setting of the challenges posed by true hybrid imaging protocols, oral and intravenous contrast use, CT versus Cs-137 PET attenuation correction, isotropic 3D CT image presentation, and hybrid image display.

Current and near future opportunities in radiation oncology therapy planning will be reviewed in the context of the challenges posed by the associated protocols, respiratory motion and data handling.  Cardiac gating, coronary artery patency/absolute flow assessments, cardiac viability and rubidium/ammonia studies will be discussed toexplore the potentials of PET/CT in cardiac imaging.  I-124 in 3D voxel based molecular therapy dosimetry, F-18 bone imaging, and other F-18 labeled compounds will be briefly covered to explore the promise of PET/CT in applications beyond FDG.